Article
08 Oct 2025
Non-binding Guidance: The Administration's Focus On Direct-to-Consumer Prescription Drug Advertising (Podcast)
AUTHORS CONTENT
Article
16 Sep 2025
The Administration Targets Direct-To-Consumer Prescription Drug Advertising
Article
27 Jan 2025
FDA Issues Draft Guidance Describing When A Confirmatory Trial Of A Drug Seeking Accelerated Approval Is "Underway"
Article
16 Jan 2025
FDA Finalizes Guidance On Communication Of Scientific Information On Unapproved Uses And Releases Updated First Amendment Analysis
Article
02 Jan 2025
Anything Worth Doing Is Worth Doing Right: FDA Issues Draft Guidance On Requirements And Processes For Accelerated Approval
Article
02 Aug 2024
Non-Binding Guidance: How Drug And Device Companies Can Tackle Internet Misinformation (Podcast)
Article
11 Mar 2024
Non-Binding Guidance: Preview Of The Second Annual Ropes & Gray Rare Disease Forum (Podcast)
Article
30 Jan 2024
U.S. Life Sciences Regulatory And Compliance Outlook 2024 (Part II): Product Development And Pricing (Podcast)
Article
02 Jan 2024
First Circuit Affirms Convictions Of Former Acclarent Executives Related To Off-Label Promotion Of Medical Device
Article
21 Nov 2023
Non-Binding Guidance: FDA's Draft Guidance On Communication Of Scientific Information On Unapproved Uses Of Medical Products (Podcast)
Article
30 Oct 2023
Try, Try Again: FDA Issues Draft Guidance On Communication Of Scientific Information On Unapproved Uses Of Medical Products
Article
07 Mar 2021
Podcast: Non-Binding Guidance: FDA Regulatory Developments In AI And Machine Learning
Article
14 Oct 2020
Digital Health Download (October 9, 2020)
Article
02 Oct 2020
Podcast: COVID-19: Non-binding Guidance: Real-World Evidence In Drug Development And The Impact Of The Pandemic
Article
10 Aug 2020
Digital Health Download
Article
10 Mar 2020
Podcast: Non-Binding Guidance: FDA Regulatory And Patent Implications Of The Transition Provision Of The Biologics Price Competition And Innovation Act
Article
13 Jan 2020
Podcast: Non-Binding Guidance: SEC Disclosure Issues For Life Sciences Companies
Article
10 Oct 2019
Life Sciences Quarterly (Q3 2019): SEC Enforcement And Class Actions Regarding FDA Communications (Video)
Article
23 Sep 2019
Podcast: Non-binding Guidance: Breakthrough Devices Program
Article
10 Sep 2019
Podcast: Non-binding Guidance: Expedited Review Programs For Drugs And Biologics